Pneumonia is a significant cause of death for children, particularly those in developing countries. The records of children who were hospitalized because of pneumonia between January 2003 and December 2015 were retrospectively reviewed, and patients who met the recurrent pneumonia criteria were included in this study. During this 13-year period, 1395 patients were hospitalized with pneumonia; of these, 129 (9.2%) met the criteria for recurrent pneumonia. Underlying diseases were detected in 95 (73.6%) patients, with aspiration syndrome (21.7%) being the most common. Rhinovirus (30.5%), adenovirus (17.2%) and respiratory syncytial virus (13.9%) were the most frequent infectious agents. These results demonstrate that underlying diseases can cause recurrent pneumonia in children. Viruses are also commonly seen in recurrent pneumonia. Appropriate treatments should be chosen based on an analysis of the underlying disease, the patient's clinical condition and the laboratory and radiological data.
1-102 months). None of the patients had a history of Rotavirus immunization. While overall complication rate was 44.2%, the most common complication related RG was electrolyte imbalance and the second common complication was septicemia (32.6% and 6.5%, respectively). Klebsiella, E. coli and Candida species were the most common isolated microorganisms from the blood cultures.Rotavirus gastroenteritis is still an important cause of morbidity in children which can cause serious complications such as sepsis. Lack of rotavirus vaccine in our national immunization program might contribute to the related complications and prolonged hospitalization, health care expenses and family work loss, as well.
Background: Bacille Calmette-Guerin (BCG) vaccine may cause some cutaneous complications at the injection site. Although some of these are normal reactions, unexpected complications may be seen. Clinical features, treatment modalities and outcomes of these complications have not been clearly defined in literature. We aimed to determine the local cutaneous complications after BCG vaccine and clinical experiences in our hospital.
Congenital lobar emphysema is a rare disease, which is characterized by pulmoner hyperinflation. Depending on the degree of bronchial obstruction, the clinical presentation may be variable. We report a rare case with congenital lobar emphysema in a 38-days-old male infant who presented with severe respiratory distress and hypertension. Air trapping in the left upper lung and significant mediastinal shift to the right were observed on the chest x-ray. Emphysematous changes were detected on the thorax computed tomography and considered as congenital lobar emphysema. The upper left lobectomy was successfully performed by pediatric surgeons. On postoperative follow up, no sign of respiratory distress occurred and the patient was normotensive. In this report, a case with congenital lobar emphysema, which is a rare cause of respiratory distress and hypertension is discussed.
SUMMARY: Tural-Kara T, Özdemir H, İnce E, İleri T, Çiftçi E. Fonsecaea pedrosoi: A rare cause of dental infection and maxillary osteomyelitis in a child with acute lymphoblastic leukemia. Turk J Pediatr 2016; 58: 679-682.Dental lesions are commonly seen in children with malignancy. We report a child with acute lymphoblastic leukemia who had black-brown dental lesion during the febrile neutropenic episode. Histopathological examination of dental lesion showed fungal hyphae and conidia. F. pedrosoi that was isolated from the tissue culture. The patient was treated with intravenous liposomal amphotericin B therapy for 5 weeks and he was discharged on oral voriconazole. On follow-up, clinical symptoms recovered. Although F. pedrosoi may be an unusual causative agent of dental infection and maxillary osteomyelitis, it should be considered in patient with black-brown lesions which do not respond to antibacterial treatment. Key words: acute lymphoblastic leukemia, children, dental infection, Fonsecaea pedrosoi, osteomyelitis.Patients with acute myeloid leukemia, relapsed leukemia, those receiving highly myelosuppressive chemotherapy and allogeneic hematopoietic stem cell transplant recipients have high risk for fungal infections. Even though invasive fungal infection related mortality can be reduced with prophylactic antifungal therapy, it still continues to be a major cause of morbidity and mortality in neutropenic patients 1 . The incidence of fungal infections in acute lymphoblastic leukemia (ALL) is reportedly 24% and it can increase with prolonged duration of neutropenia 2 . C h r o m o b l a s t o m y c o s i s p e r s e , i s a n infection of skin and subcutaneous tissue 3 .Chromoblastomycosis is a well-established disease caused by F. pedrosoi and have just a few case reports. However, F. pedrosoi associated dental infections and maxillary osteomyelitis have not been reported. To our knowledge, this is the first reported pediatric case of dental infection and maxillary osteomyelitis caused by F. pedrosoi. Case ReportA 6-year-old boy with a diagnosis of standard risk B precursor ALL presented with fever on the 43 rd day of delayed intensification therapy as per COG AALL0331 chemotherapy regimen. On physical examination, he was febrile and pale. His vital signs included a temperature of 39 ºC, heart rate of 128 beats per minute, respiratory rate of 32 breaths per minute, and a blood pressure of 86/52 mmHg. He had 3 cm hepatomegaly below the right costal margin and 2 cm splenomegaly below the left costal margin. The rest of physical examination was normal, and no infectious focus was detected. Patient's laboratory test results were as followed; hemoglobin 11.7 g/dl, white blood cell count 0.2x10 3 /mm 3 , absolute neutrophil count 0/mm 3 (neutrophils 0%, lymphocytes 90%, monocytes 4% and eosinophils 6%), platelet count 16x10 3 /mm 3 , C-reactive protein 62 mg/L. He was started on intravenous cefoperazone-sulbactam for fever and neutropenia. The following day, intravenous teicoplanin and acyclovir were
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
334 Leonard St
Brooklyn, NY 11211
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.